The source provided identifies a review article titled “Immuno-metabolic crosstalk in osteoarthritis: from mechanisms to therapies” published in Frontiers in Immunology. The publisher page and URL indicate this is a REVIEW article (DOI-like identifier present in the link). However, the substantive body of the review (abstract, main text, figures, tables, and references) was not included in the supplied source material.
Because the article text itself was not present in the source, this editorial rewrite reports the article's metadata and availability status only. No mechanistic summaries, data, or therapy descriptions can be quoted or paraphrased from the review because those elements were not provided.
The source did not supply the review’s stated objectives, scope, or structured abstract. The title indicates a focus on immuno-metabolic interactions in osteoarthritis and a translational interest in moving from mechanistic understanding toward therapies, but no specific aims, questions, or hypotheses were reported in the supplied content.
The review’s core topic—how immune responses and metabolic alterations interact in osteoarthritis—is suggested by the title, but the source did not include any of the review’s explanatory text. Therefore, specific mechanisms, experimental models, biomarker data, or pathway diagrams that the authors may have described are not available and are not summarized here.
Potential cellular contributors (for example, macrophages, chondrocytes, synoviocytes, T cells) and molecular mediators (such as cytokines, chemokines, metabolic enzymes, or signaling molecules) are not described in the provided source text. No authoritative list or discussion from the review can be reproduced because those sections were not included.
Although the article title implies involvement of metabolic pathways in osteoarthritis pathogenesis, the supplied content did not include any discussion of which metabolic processes (for example, glycolysis, oxidative phosphorylation, lipid metabolism, or amino acid metabolism) were implicated. Specific pathway evidence, experimental measures, or conceptual models were not reported in the source material available for this task.
The title indicates the review likely addresses therapeutic translation, but the source did not provide any therapeutic recommendations, candidate drugs, biologics, metabolic modulators, lifestyle interventions, or clinical trial evidence. No efficacy, safety, or guideline-related statements from the review are available to summarize.
The review likely identifies knowledge gaps and future directions, but those elements were not present in the supplied source. Consequently, specific unmet needs, priority research questions, or suggested trial designs cannot be extracted or restated.
The review’s concluding messages, clinical takeaways, and authors’ recommendations are not available in the provided source text and therefore are not reproduced in this summary. Any attempt to infer conclusions would risk introducing inaccuracies and is avoided.
Available metadata in the supplied source:
For clinicians, researchers, and editors who require the review’s substantive content (mechanisms, experimental data, therapeutic discussion, figures, or references), consult the full article on the Frontiers in Immunology website or the original DOI page. This rewrite intentionally refrains from inventing or extrapolating mechanistic or therapeutic claims because those details were not present in the supplied source and must be verified directly from the published review.